ventoDr. Máximo Vento

e-Mail: 

Phone: +34 96 124 56 88



Dr. Vento graduated from the Faculty of Medicine (University of Valencia; Spain) where he also obtained his PhD degree. He completed the Residency training in Pediatrics and Fellowship in Neonatology at the Division of Neonatology of the Maternal & Children’s University Hospital La Fe (Valencia; Spain).  In 1989 his was appointed tenure professor in Pediatrics (University of Alicante; Spain).  Dr. Vento has been appointed Director of the Neonatal Research Unit which constitutes one the credited groups in the Health Research Institute and Division Chief of the Maternity and Outpatient Clinics of the Division of Neonatology (University & Polytechnic Hospital La Fe; Valencia).

Dr. Vento’s main areas of basic and clinical research in the last two decades have been related to oxygen metabolism, oxidative stress, hypoxia-reoxygenation, perinatal oxygen toxicity, fetal to neonatal transition, asphyxia and resuscitation. In this field he has contributed with clinical and experimental studies adverting about oxygen toxicity and leading to changes in the recently published international resuscitation guidelines (ILCOR 2010). In addition he has performed research in other specific neonatal areas such as nutrition, infectious diseases and developmental care.

Along his professional career Dr Vento has been visiting professor at the Division of Neonatology (Department of Pediatrics; University of Alberta; Alberta; Canada) and at the Division of Neonatology (Department of Pediatrics; Klinikum der Johannes Gutenberg Universität; Mainz; Germany). In addition, he has performed various stages at different Universities in Canada and US.

At present Dr. Vento is Vice-president of the Spanish Neonatal Society and President of the Research Committee of the Spanish Pediatric Association. In addition, recently he has been promoted to Deputy Chairman of the European Association of Perinatal Medicine. Dr. Vento is active member of the European Society for Paediatric Research, Society for Pediatric Research (US), Perinatal Group of the Spanish Society for Biochemistry and Molecular Biology and The Oxygen Society (US).

Dr. Vento was appointed Honorary Member of the American Pediatric Society in 2007 and of the Deutsche Gesellschaft für Kinderheilkunde in 2008.

Under the leadership of Prof. Adolf Valls-i-Soler, Dr. Vento joined the Maternal & Child Network supported by the Instituto Carlos III.  He aims to establish a network of excellence including the most neonatal divisions in Spain that will allow undertaking sufficiently powered clinical trials.

He has written over 100 papers most of them in peer reviewed international journals, and more than 30 book chapters in internationally relevant neonatal handbooks. He is especially proud of being together with Dr. O.D. Saugstad author of the chapter on Oxygen Toxicity in the Fanaroff, Martin, Walsh Neonatal Perinatal Medicine handbook. Moreover, he has been invited to give more than 50 conferences at national and international congresses, symposiums, and scientific meetings. The hallmark of the recognition at an international level in the field of neonatology was his appointment as featured speaker for the Bengt Robertson Conference at the ESPR meeting held in 2010 in Copenhaguen, and featured speaker at The Lung Club Conference at the Pediatric Academic Societies Meeting held in Boston in 2012.

Dr. Vento has been extensively funded by the Instituto Carlos III (Spanish Government) and the Ministry of Health and Innovation, and has been recently appointed as member of the Commission for Grant Approval in the field of Maternal and Child Health (Instituto Carlos III; Ministry of Economy & Innovation).

His present clinical endeavors are launching an international multicenter prospective randomized trial on resuscitation of extreme preterm with Prof. NN Finer (University of California at San Diego) and Prof. O.D. Saugstad (University of Oslo) under the acronym PRESOX Trial, and also a multicenter Spanish prospective, randomized, double-blind placebo-control trial on the use of topiramate vs. placebo in asphyxiated babies treated with whole body moderate hypothermia under the acronym HYPOTOP Trial.

In the experimental field, Dr. Vento and the members of his team are closely working with other groups with different animal models and strategies in the US (Dr RJ Martin; Case Western Reserve; Cleveland), Canada (Dr PY Cheung; U. of Alberta; Dr J Belik; U of Toronto) and Norway (Dr OD Saugstad) in order to unravel basic mechanisms and gene expression of oxygen toxicity and response to hypoxia, hyperoxia and re-oxygenation.